BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1957 related articles for article (PubMed ID: 11781953)

  • 1. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long QT syndromes: genetic basis and clinical implications.
    Chiang CE; Roden DM
    J Am Coll Cardiol; 2000 Jul; 36(1):1-12. PubMed ID: 10898405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population.
    Allan WC; Timothy K; Vincent GM; Palomaki GE; Neveux LM; Haddow JE
    J Med Screen; 2001; 8(4):173-7. PubMed ID: 11743032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.
    Jongbloed RJ; Wilde AA; Geelen JL; Doevendans P; Schaap C; Van Langen I; van Tintelen JP; Cobben JM; Beaufort-Krol GC; Geraedts JP; Smeets HJ
    Hum Mutat; 1999; 13(4):301-10. PubMed ID: 10220144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
    Witchel HJ; Hancox JC
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.
    Swan H; Viitasalo M; Piippo K; Laitinen P; Kontula K; Toivonen L
    J Am Coll Cardiol; 1999 Sep; 34(3):823-9. PubMed ID: 10483966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac arrhythmias: the genetic connection.
    Towbin JA
    J Cardiovasc Electrophysiol; 2000 May; 11(5):601-2. PubMed ID: 10826942
    [No Abstract]   [Full Text] [Related]  

  • 13. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1).
    Wilde AA; Jongbloed RJ; Doevendans PA; Düren DR; Hauer RN; van Langen IM; van Tintelen JP; Smeets HJ; Meyer H; Geelen JL
    J Am Coll Cardiol; 1999 Feb; 33(2):327-32. PubMed ID: 9973011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.
    Yang P; Kanki H; Drolet B; Yang T; Wei J; Viswanathan PC; Hohnloser SH; Shimizu W; Schwartz PJ; Stanton M; Murray KT; Norris K; George AL; Roden DM
    Circulation; 2002 Apr; 105(16):1943-8. PubMed ID: 11997281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic background predisposing the drug-induced long QT syndrome].
    Horie M
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):401-7. PubMed ID: 12835534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
    Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
    Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
    Priori SG; Cantù F; Schwartz PJ
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia.
    Sanguinetti MC
    Ann N Y Acad Sci; 1999 Apr; 868():406-13. PubMed ID: 10414310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.